Phase 2 Multicohort Study to Evaluate the Safety and Efficacy of Novel Treatment Combinations in Patients With Recurrent Ovarian Cancer

What is the purpose of this trial?

This study is a phase 2, multi-cohort study, which will assess the safety and efficacy of new treatment combinations in patients with recurrent ovarian cancer.



TESARO, Inc

Start Date: 02/25/2019

End Date: 07/01/2020

Last Updated: 02/27/2019

Study HIC#: 2000023388

Get Involved

For more information about this study, contact:
Michele Hill
+1 203-737-7660
michele.montagna@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image